The global New Shingles Vaccine market size is predicted to grow from US$ 1238 million in 2025 to US$ 1534 million in 2031; it is expected to grow at a CAGR of 3.6% from 2025 to 2031.

The new shingles vaccine is a vaccine used to prevent herpes zoster (commonly known as "shingles"), which mainly stimulates the immune system to produce antibodies against the varicella-zoster virus (VZV), thereby reducing the risk of shingles infection in the elderly and those with weakened immunity, and reducing the pain and complications caused by the disease. This vaccine usually contains highly effective active ingredients that can significantly enhance the body's immune response, is more effective than traditional vaccines, and can provide long-term protection, especially for people over 50 years old.

United States market for New Shingles Vaccine is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for New Shingles Vaccine is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for New Shingles Vaccine is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key New Shingles Vaccine players cover Pfizer, GSK, Merck, Sanofi, Novartis, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the “New Shingles Vaccine Industry Forecast” looks at past sales and reviews total world New Shingles Vaccine sales in 2024, providing a comprehensive analysis by region and market sector of projected New Shingles Vaccine sales for 2025 through 2031. With New Shingles Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world New Shingles Vaccine industry.
This Insight Report provides a comprehensive analysis of the global New Shingles Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on New Shingles Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global New Shingles Vaccine market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for New Shingles Vaccine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global New Shingles Vaccine.

This report presents a comprehensive overview, market shares, and growth opportunities of New Shingles Vaccine market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

    Live Attenuated Vaccines
    Recombinant Vaccines

Segmentation by Application:

    Subcutaneous Vaccines
    Intradermal Vaccines

This report also splits the market by region:

    Americas

        United States
        Canada
        Mexico
        Brazil

    APAC

        China
        Japan
        Korea
        Southeast Asia
        India
        Australia

    Europe

        Germany
        France
        UK
        Italy
        Russia

    Middle East & Africa

        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

    Pfizer
    GSK
    Merck
    Sanofi
    Novartis
    Yidao Biotechnology
    Jiangsu Ruike Biotechnology
    Beijing Luzhu Biotechnology

Key Questions Addressed in this Report

What is the 10-year outlook for the global New Shingles Vaccine market?
What factors are driving New Shingles Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do New Shingles Vaccine market opportunities vary by end market size?
How does New Shingles Vaccine break out by Type, by Application?